Atypical Fractures are Mainly Subtrochanteric in Singapore and Diaphyseal in Sweden: A Cross-Sectional Study

Journal of Bone and Mineral Research

Volumn 30, Issue 11, 2015, Pages 2127-2132

  Schilcher, Jörg ^a   Howe, Tet Sen ^b   Png, Meng Ai ^b   Aspenberg, Per ^a   Koh, Joyce S B ^b  

^a LINKÖPING UNIVERSITY   (Sweden)

^b SINGAPORE GENERAL HOSPITAL   (Singapore)

Author keywords

ANTIRESORPTIVES; BIOMECHANICS; INJURY FRACTURE HEALING; OSTEOPOROSIS; RADIOLOGY

Indexed keywords

ADULT; ANATOMICAL VARIATION; ARTICLE; BONE RADIOGRAPHY; CROSS-SECTIONAL STUDY; DIAPHYSEAL FRACTURE; FEMALE; FEMUR FRACTURE; FEMUR SUBTROCHANTERIC FRACTURE; FRACTURE; HUMAN; LESSER TROCHANTER; MAJOR CLINICAL STUDY; MALE; SINGAPORE; SWEDEN; DIAPHYSIS; DRUG EFFECTS; FEMORAL FRACTURES; FEMUR; HIP FRACTURES; PATHOLOGY; PROBABILITY; RADIOGRAPHY;

BISPHOSPHONIC ACID DERIVATIVE;

CROSS-SECTIONAL STUDIES; DIAPHYSES; DIPHOSPHONATES; FEMORAL FRACTURES; FEMUR; HIP FRACTURES; HUMANS; PROBABILITY; SINGAPORE; SWEDEN;

EID: 84945459569     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.2547     Document Type: Article

References (25)

1. Kwek EB, Goh SK, Koh JSB, Png MA, Howe TS., An emerging pattern of subtrochanteric stress fractures: a long-term complication of alendronate therapy? Injury. 2008; 39 (2): 224-31.
2. Girgis CM, Sher D, Seibel MJ., Atypical femoral fractures and bisphosphonate use. N Engl J Med. 2010; 362 (19): 1848-9.
3. Lo JC, Huang SY, Lee GA, et al., Clinical correlates of atypical femoral fracture. Bone. 2012; 51 (1): 181-4.
4. Lenart BA, Lorich DG, Lane JM., Atypical fractures of the femoral diaphysis in postmenopausal women taking alendronate. N Engl J Med. 2008; 358 (12): 1304-6.
5. Koeppen VA, Schilcher J, Aspenberg P., Dichotomous location of 160 atypical femoral fractures. Acta Orthop. 2013; 84 (6): 561-4.
6. Neviaser AS, Lane JM, Lenart BA, Edobor-Osula F, Lorich DG., Low-energy femoral shaft fractures associated with alendronate use. J Orthop Trauma. 2008; 22 (5): 346-50.
7. Schilcher J, Aspenberg P., Incidence of stress fractures of the femoral shaft in women treated with bisphosphonate. Acta Orthop. 2009; 80 (4): 413-5.
8. Koh JS, Goh SK, Png MA, Ng AC, Howe TS., Distribution of atypical fractures and cortical stress lesions in the femur: implications on pathophysiology. Singapore Med J. 2011 Feb; 52 (2): 77-80.
9. Martelli S, Pivonka P, Ebeling PR., Femoral shaft strains during daily activities: Implications for atypical femoral fractures. Clin Biomech (Bristol, Avon). 2014; 29 (8): 869-76.
10. Koch JC., The laws of bone architecture. Am J Anat. 1917; 21 (2): 177-298.
11. Maratt J, Schilling PL, Holcombe S, et al., Variation in the femoral bow: a novel high-throughput analysis of 3922 femurs on cross-sectional imaging. J Orthop Trauma. 2014; 28 (1): 6-9.
12. Chen LP, Chang TK, Huang TY, Kwok TG, Lu YC., The correlation between lateral bowing angle of the femur and the location of atypical femur fractures. Calcif Tissue Int. 2014 Sep; 95 (3): 240-7.
13. Ng AC, Png MA, Mohan PC, Koh JS, Howe TS., Atypical femoral fractures: transverse morphology at lateral cortex is a critical feature. J Bone Miner Res. 2014; 29 (3): 639-43.
14. Schilcher J, Koeppen V, Aspenberg P, Michaelsson K., Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med. 2014; 371 (10): 974-6.
15. Schilcher J, Michaelsson K, Aspenberg P., Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med. 2011; 364 (18): 1728-37.
16. Shane E, Burr D, Abrahamsen B, et al., Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2014; 29 (1): 1-23.
17. Schilcher J, Koeppen V, Ranstam J, Skripitz R, Michaelsson K, Aspenberg P., Atypical femoral fractures are a separate entity, characterized by highly specific radiographic features. A comparison of 59 cases and 218 controls. Bone. 2013; 52 (1): 389-92.
18. Fraley C, Raftery AE., Model-based clustering, discriminant analysis and density estimation. J Am Stat Assoc. 2002; 97: 611-31.
19. Fraley C, Raftery AE, Murphy TB, Scrucca L., mclust version 4 for R: normal mixture modeling for model-based clustering, classification, and density estimation. Technical Report No. 597. Seattle, WA, USA: Department of Statistics, University of Washington; 2012. Available from: https://www.stat.washington.edu/research/reports/2012/tr597.pdf
20. Michaelsson K, Baron JA, Snellman G, et al., Plasma vitamin D and mortality in older men: a community-based prospective cohort study. Am J Clin Nutr. 2010; 92 (4): 841-8.
21. Snellman G, Byberg L, Lemming EW, et al., Long-term dietary vitamin D intake and risk of fracture and osteoporosis: a longitudinal cohort study of Swedish middle-aged and elderly women. J Clin Endocrinol Metab. 2014; 99 (3): 781-90.
22. Taormina DP, Marcano AI, Karia R, Egol KA, Tejwani NC., Symptomatic atypical femoral fractures are related to underlying hip geometry. Bone. 2014; 63: 1-6.
23. Hagen JE, Miller AN, Ott SM, et al., Association of atypical femoral fractures with bisphosphonate use by patients with varus hip geometry. J Bone Joint Surg Am. 2014; 96 (22): 1905-9.
24. Morin SN, Godbout B, Wall M, et al., Femur geometrical parameters in the pathogenesis of atypical femur fractures. Presented at the European Calcified Tissue Society (ECTS) 2013. Bone Abstracts. May 2013, Volume 1. May 18-21 2013, Lisbon, Portugal. DOI:10.1530/boneabs.1 OC1. 6. Available from: http://www.bone-abstracts.org/ba/0001/ECTS2013AbstractBook.pdf
25. Sasaki S, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y., Low-energy diaphyseal femoral fractures associated with bisphosphonate use and severe curved femur: a case series. J Bone Miner Metab. 2012; 30 (5): 561-7.